Finding End-To-End ADC CDMO Solutions

Proveo™ offers a comprehensive and efficient solution for the development and manufacturing of antibody-drug conjugates (ADCs), seamlessly integrating the expertise of three industry leaders to support projects from early development through commercial production.

This innovative partnership combines AGC Biologics’ specialized capabilities in monoclonal antibody production, Cerbios’ deep expertise in bioconjugation and linker-payload technologies, and Oncotec’s proficiency in aseptic fill and lyophilization of ADC drug products. By uniting these strengths into a single, streamlined solution, Proveo™ accelerates timelines, ensures quality, and simplifies the complex ADC development and manufacturing process.